Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 176

Results For "National"

2145 News Found

Govt earmarks Rs 500 crore for pharma clusters and MSMEs
Policy | March 12, 2022

Govt earmarks Rs 500 crore for pharma clusters and MSMEs

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme


China approves BeiGene’s tislelizumab
Drug Approval | March 12, 2022

China approves BeiGene’s tislelizumab

Tislelizumab is now approved for seven indications in China


Moderna begins Phase 2 study of Omicron-specific bivalent booster
Biotech | March 11, 2022

Moderna begins Phase 2 study of Omicron-specific bivalent booster

Moderna's Omicron-specific bivalent booster candidate combines its Omicron-specific booster candidate with its Covid-19 vaccine


Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals
interviews | March 10, 2022

Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals

As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma


Everlife acquires Research Instruments to boost presence in life science and clinical diagnostics
News | March 10, 2022

Everlife acquires Research Instruments to boost presence in life science and clinical diagnostics

The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months


Artificial retinal device mimics human optical illusions: WPI-MANA
Biotech | March 10, 2022

Artificial retinal device mimics human optical illusions: WPI-MANA

The team built a multiple ionic device system, each of which had a lithium cobalt oxide channel arranged on a common lithium phosphorus oxynitride electrolyte


Lupin Diagnostics opens first Reference Lab in East India
Clinical Trials | March 10, 2022

Lupin Diagnostics opens first Reference Lab in East India

It is also setting up laboratories in West Bengal, Assam, Bihar, Jharkhand and Orissa to comprehensively cater to the East India region


Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada
People | March 09, 2022

Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada

With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies


Venus Remedies wins WHO GDP certification
Supply Chain | March 09, 2022

Venus Remedies wins WHO GDP certification

Internationally accepted pharmaceutical GDP regulations stipulate that distributors of pharmaceutical products and warehouses must align their operations with the specified standards


SRL Diagnostics report indicates women neglect routine tests
Clinical Trials | March 09, 2022

SRL Diagnostics report indicates women neglect routine tests

Routine tests undertaken by women dropped by 35% in 2020